The vaccines that could make a big impact on healthcare, from radical new flu vaccines to simplified meningococcal vaccine regimens.
With so many new immunotherapy treatments on the horizon, pharmacists need to understand the ins and outs of immuno-oncology biomarkers to best serve their patients.
Patients taking heart medications are most at risk when a pharmacy shuts its doors.
The real-world strategies used to manage the high cost of specialty meds.
The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?
DOACs are as good as warfarin in preventing atrial fibrillation complications.
Three cardiology groups now recommend using NOACs over warfarin in atrial fibrillation.
Advice from pharmacists whom have adopted new approaches in their practice.
The risk of gastrointestinal bleeding appears to be highest with rivaroxaban and lowest with apixaban, but is reduced by cotherapy with proton pump inhibitors.
Walgreens' new integrated support program aims to help patients with cancer manage the side effects of undergoing treatment. Here’s five things to know about it.